Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Cooper

Showing results (81-90 of 324) with videos related to

Pageof 33
Sort By:
Lancet (London, England)|October 26, 2005
HIV prevention research in a resource-limited setting: the experience of planning a trial in CambodiaKimberly Page-Shafer, Vonthanak Saphonn, Ly Penh Sun, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 10, 2011
CD4 cell responses to combination antiretroviral therapy in patients starting therapy at high CD4 cell countsStephen T Wright, Andrew Carr, Ian Woolley, et al.
Nucleic Acids Research|November 9, 2011
Direct evidence of nuclear Argonaute distribution during transcriptional silencing links the actin cytoskeleton to nuclear RNAi machinery in human cellsChantelle L Ahlenstiel, Heidi G W Lim, David A Cooper, et al.
The Australasian Journal of Dermatology|February 22, 2011
Enfuvirtide injection site reactions: a clinical and histopathological appraisalBrian J Wallace, King-Bing Tan, Sarah L Pett, et al.
AIDS (London, England)|November 1, 2002
A randomized, double-blind study of gemfibrozil for the treatment of protease inhibitor-associated hypertriglyceridaemiaJohn Miller, Dannae Brown, Janaki Amin, et al.
The Journal of Infectious Diseases|July 24, 2004
Changes in mitochondrial DNA in peripheral blood mononuclear cells from HIV-infected patients with lipoatrophy randomized to receive abacavirJennifer F Hoy, Michelle E Gahan, Andrew Carr, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 17, 2009
CD4+ T-cell restoration after 48 weeks in the maraviroc treatment-experienced trials MOTIVATE 1 and 2David M Asmuth, James Goodrich, David A Cooper, et al.
The Journal of Biological Chemistry|June 4, 2008
Closed chromatin architecture is induced by an RNA duplex targeting the HIV-1 promoter regionKazuo Suzuki, Torsten Juelich, Heidi Lim, et al.
Plos One|June 27, 2014
Moving away from Ritonavir, Abacavir, Tenofovir, and Efavirenz (RATE)--agents that concern prescribers and patients: a feasibility study and call for a trialAmit C Achhra, Mark A Boyd, Matthew G Law, et al.
AIDS (London, England)|November 1, 2002
The CD4 cell count 3 months after acute retroviral syndrome is associated with the presence of AIDS in the source individualPhilippe Vanhems, Emmanuelle Caillat-Vallet, Bernard Hirschel, et al.
Pageof 33

Showing results (81-90 of 324) with videos related to

Sort By:
Pageof 33
Lancet (London, England)|October 26, 2005
HIV prevention research in a resource-limited setting: the experience of planning a trial in CambodiaKimberly Page-Shafer, Vonthanak Saphonn, Ly Penh Sun, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 10, 2011
CD4 cell responses to combination antiretroviral therapy in patients starting therapy at high CD4 cell countsStephen T Wright, Andrew Carr, Ian Woolley, et al.
Nucleic Acids Research|November 9, 2011
Direct evidence of nuclear Argonaute distribution during transcriptional silencing links the actin cytoskeleton to nuclear RNAi machinery in human cellsChantelle L Ahlenstiel, Heidi G W Lim, David A Cooper, et al.
The Australasian Journal of Dermatology|February 22, 2011
Enfuvirtide injection site reactions: a clinical and histopathological appraisalBrian J Wallace, King-Bing Tan, Sarah L Pett, et al.
AIDS (London, England)|November 1, 2002
A randomized, double-blind study of gemfibrozil for the treatment of protease inhibitor-associated hypertriglyceridaemiaJohn Miller, Dannae Brown, Janaki Amin, et al.
The Journal of Infectious Diseases|July 24, 2004
Changes in mitochondrial DNA in peripheral blood mononuclear cells from HIV-infected patients with lipoatrophy randomized to receive abacavirJennifer F Hoy, Michelle E Gahan, Andrew Carr, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 17, 2009
CD4+ T-cell restoration after 48 weeks in the maraviroc treatment-experienced trials MOTIVATE 1 and 2David M Asmuth, James Goodrich, David A Cooper, et al.
The Journal of Biological Chemistry|June 4, 2008
Closed chromatin architecture is induced by an RNA duplex targeting the HIV-1 promoter regionKazuo Suzuki, Torsten Juelich, Heidi Lim, et al.
Plos One|June 27, 2014
Moving away from Ritonavir, Abacavir, Tenofovir, and Efavirenz (RATE)--agents that concern prescribers and patients: a feasibility study and call for a trialAmit C Achhra, Mark A Boyd, Matthew G Law, et al.
AIDS (London, England)|November 1, 2002
The CD4 cell count 3 months after acute retroviral syndrome is associated with the presence of AIDS in the source individualPhilippe Vanhems, Emmanuelle Caillat-Vallet, Bernard Hirschel, et al.
Pageof 33